Featured Articles
March 17, 2021
Dapivirine Vaginal Ring Added to WHO Clinical Guidelines as HIV Prevention Choice for Women
March 17, 2021—The World Health Organization (WHO) has updated its clinical guidelines on antiretroviral (ARV) drugs for HIV prevention to include a recommendation for IPM’s monthly dapivirine... More »
March 08, 2021
By Women, For Women: An International Women's Day Story Collection
March 8, 2021—Happy International Women's Day! Here at IPM, women are at the core of everything we do—from developing woman-centered and woman-controlled HIV prevention and other sexual and... More »
March 05, 2021
Hope for the Future: My Experience With the Dapivirine Ring
March 5, 2021We spoke to Akhona Gxarisa, a 27-year-old primary school teacher in Cape Town, South Africa who participated in the Ring Study and DREAM. She tells us about her experience in the... More »
February 01, 2021
Dapivirine ring OLE study results featured in The Lancet HIV
February 1, 2021—Primary results from two open-label extension studies (OLEs) of IPM’s dapivirine vaginal ring, DREAM and HOPE, are featured in The Lancet HIV’s February 2021 issue. The publications... More »
January 26, 2021
Join IPM at HIV R4P 2021!
January 26, 2021—We hope you will join IPM for the 4th HIV Research for Prevention (R4P) Conference, taking place virtually January 27-28 and February 3-4, 2021! Learn about the latest research on... More »